GeneDx Holdings Corp. (WGS)
NASDAQ · Healthcare
GeneDx Holdings Corp. Balance Sheet 2019–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total Assets | 523.7M | 419.4M | 418.8M | 490.9M | 554.1M | 251.6M |
| Cash & Equivalents | 105.0M | 85.2M | 99.7M | 123.9M | 400.6M | 108.1M |
| Liabilities | ||||||
| Total Liabilities | 215.5M | 174.1M | 190.7M | 237.2M | 166.0M | 247.3M |
| Long-Term Debt | 54.5M | 55.8M | 56.3M | 11.0M | 11.0M | 19.0M |
| Equity | ||||||
| Shareholders' Equity | 308.2M | 245.2M | 228.0M | 253.7M | 388.1M | -330.1M |
GeneDx Holdings Corp. Balance Sheet — FAQ
GeneDx Holdings Corp. (WGS) balance sheet over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see WGS's balance sheet history?
The chart and table above show GeneDx Holdings Corp.'s balance sheet by year and by quarter, including the growth rate.